AUD 0.02
(0.0%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 | 670.19 Thousand NZD | -80.3% |
2023 | 3.4 Million NZD | -63.77% |
2022 | 9.38 Million NZD | 105.79% |
2021 | 4.56 Million NZD | -1.56% |
2020 | 4.63 Million NZD | -6.23% |
2019 | 4.94 Million NZD | -4.89% |
2018 | 5.19 Million NZD | 19.27% |
2017 | 4.35 Million NZD | 52.58% |
2016 | 2.85 Million NZD | 71.59% |
2015 | 1.66 Million NZD | -29.61% |
2014 | 2.36 Million NZD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 856.71 Thousand NZD | 6.87% |
2024 Q3 | 752.17 Thousand NZD | -12.2% |
2024 FY | 3.21 Million NZD | -5.41% |
2024 Q2 | 856.71 Thousand NZD | 0.0% |
2024 Q4 | 695.85 Thousand NZD | -7.49% |
2023 Q2 | 838.95 Thousand NZD | 0.0% |
2023 Q3 | 801.67 Thousand NZD | -4.44% |
2023 Q1 | 838.95 Thousand NZD | -76.4% |
2023 FY | 3.4 Million NZD | -63.77% |
2023 Q4 | 801.67 Thousand NZD | 0.0% |
2022 Q4 | 3.55 Million NZD | 0.0% |
2022 FY | 9.38 Million NZD | 105.79% |
2022 Q3 | 3.55 Million NZD | 256.62% |
2022 Q2 | 996.97 Thousand NZD | 0.0% |
2022 Q1 | 996.97 Thousand NZD | -22.75% |
2021 Q1 | 1.05 Million NZD | -54.09% |
2021 FY | 4.56 Million NZD | -1.56% |
2021 Q2 | 1.05 Million NZD | 0.0% |
2021 Q4 | 1.29 Million NZD | 0.0% |
2021 Q3 | 1.29 Million NZD | 21.88% |
2020 Q3 | 2.3 Million NZD | 100.99% |
2020 Q2 | 1.14 Million NZD | 0.0% |
2020 FY | 4.63 Million NZD | -6.23% |
2020 Q4 | 2.3 Million NZD | 0.0% |
2020 Q1 | 1.14 Million NZD | -21.43% |
2019 Q3 | 1.46 Million NZD | 32.67% |
2019 Q1 | 1.1 Million NZD | -34.82% |
2019 Q2 | 1.1 Million NZD | -0.0% |
2019 Q4 | 1.46 Million NZD | 0.0% |
2019 FY | 4.94 Million NZD | -4.89% |
2018 FY | 5.19 Million NZD | 19.27% |
2018 Q3 | 1.68 Million NZD | 56.24% |
2018 Q4 | 1.68 Million NZD | 0.0% |
2018 Q1 | 1.08 Million NZD | -0.33% |
2018 Q2 | 1.08 Million NZD | -0.0% |
2017 Q2 | 1.12 Million NZD | -0.0% |
2017 Q4 | 1.08 Million NZD | 0.0% |
2017 FY | 4.35 Million NZD | 52.58% |
2017 Q3 | 1.08 Million NZD | -3.9% |
2017 Q1 | 1.12 Million NZD | 43.53% |
2016 Q1 | 554.4 Thousand NZD | -5.12% |
2016 FY | 2.85 Million NZD | 71.59% |
2016 Q3 | 786.24 Thousand NZD | 41.82% |
2016 Q4 | 786.24 Thousand NZD | 0.0% |
2016 Q2 | 554.4 Thousand NZD | 0.0% |
2015 Q2 | 302.33 Thousand NZD | -0.0% |
2015 Q3 | 584.32 Thousand NZD | 93.27% |
2015 FY | 1.66 Million NZD | -29.61% |
2015 Q4 | 584.32 Thousand NZD | 0.0% |
2015 Q1 | 302.33 Thousand NZD | 0.0% |
2014 FY | 2.36 Million NZD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
4DMedical Limited | 31.48 Million AUD | 97.871% |
Adherium Limited | 267.7 Thousand AUD | -150.349% |
Aroa Biosurgery Limited | 66.09 Million AUD | 98.986% |
Atomo Diagnostics Limited | 1.6 Million AUD | 58.27% |
Anteris Technologies Ltd | 69.14 Million AUD | 99.031% |
Control Bionics Limited | 9.82 Million AUD | 93.179% |
CardieX Limited | 16.64 Million AUD | 95.975% |
Compumedics Limited | 26.88 Million AUD | 97.507% |
Cochlear Limited | 1.17 Billion AUD | 99.943% |
CleanSpace Holdings Limited | 11.35 Million AUD | 94.1% |
Cyclopharm Limited | 13.38 Million AUD | 94.991% |
EMVision Medical Devices Ltd | 12.83 Million AUD | 94.778% |
Nova Eye Medical Limited | 23.99 Million AUD | 97.206% |
HeraMED Limited | 6.78 Million AUD | 90.119% |
Imricor Medical Systems, Inc. | -1.11 Million AUD | 160.062% |
ImpediMed Limited | 28.04 Million AUD | 97.61% |
InhaleRx Limited | 2.59 Million AUD | 74.129% |
LBT Innovations Limited | 1.1 Million AUD | 39.459% |
Micro-X Limited | 18.76 Million AUD | 96.428% |
Neurotech International Limited | 8.75 Million AUD | 92.344% |
OncoSil Medical Limited | 12.03 Million AUD | 94.434% |
PolyNovo Limited | 34.92 Million AUD | 98.081% |
Respiri Limited | 8.03 Million AUD | 91.659% |
SomnoMed Limited | 58.97 Million AUD | 98.864% |
Universal Biosensors, Inc. | 20 Million AUD | 96.649% |
Uscom Limited | 5.52 Million AUD | 87.859% |
Visioneering Technologies, Inc. | 9.63 Million AUD | 93.043% |